Covid 19 update

Covid-19 Public Health Policy Implications Commentary and Analysis

Below is the extracted article published on the 6th of October 2020 by the highly respected Stanford Professor John Ioannidis –  Global Perspective of Covid-19 Epidemiology for a Full-Cycle Pandemic. The argument he presents is one that public health policy needs to be far more sophisticated in its approach to Covid-19.

The blanket lockdown of whole communities, he argues, ignores the very stratified risks that communities run. Extremely low risk in the working age population against higher risk for those above 70. He notes that the data is most probably bad and questions what he sees as a lack of constant distinction between deaths from Covid-19 and deaths with Covid-19.

He estimates that the extent of infection is of the order of 10% in populations and most are either asymptomatic or mild. The corollary is that as testing ramps up the apparent number of cases also ramps up. A totally misleading interpretation of the data.

He foresees that there may be an extended period when the virus is active, but that with more nuanced and focussed public health policy the proportion of total deaths would be reduced to a small number. He also points to the extensive collateral damage to public health that has occurred as a result of the clumsy implementation of policy. The treatment may have been worse than the disease!

The data released by governments and health authorities does not really point to the nature of the disease so this analysis of the data by an eminent medical and public health professional is a valuable contribution. Could it be that massive and unnecessary damage has been done to economies?

Source: https://onlinelibrary.wiley.com/doi/epdf/10.1111/eci.13423

John P. A. Ioannidis is a Greek-American physician-scientist, writer and Stanford University professor who has made contributions to evidence-based medicineepidemiology, and clinical research. Ioannidis studies scientific research itself, meta-research primarily in clinical medicine and the social sciences.

PPM is a boutique investment manager focused on generating superior long-term, tax effective returns.

CONTACT US

The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.

Close*Research Ratings Disclaimer